This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
MITRA Stoklara Genel Bakış
Develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally.
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 3/6 |
| Gelecekteki Büyüme | 5/6 |
| Geçmiş Performans | 0/6 |
| Finansal Sağlık | 1/6 |
| Temettüler | 0/6 |
Mithra Pharmaceuticals SA Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | €0.22 |
| 52 Haftanın En Yüksek Seviyesi | €2.29 |
| 52 Haftanın En Düşük Seviyesi | €0.20 |
| Beta | 0.51 |
| 11 Aylık Değişim | 0% |
| 3 Aylık Değişim | 0% |
| 1 Yıllık Değişim | -90.11% |
| 33 Yıllık Değişim | -98.79% |
| 5 Yıllık Değişim | -99.27% |
| Halka arzdan bu yana değişim | -98.19% |
Son Haberler & Güncellemeler
Recent updates
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%
Apr 06
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive
Feb 07Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts
Nov 09These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts
Oct 05Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)
May 23Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts
Aug 11Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%
Mar 13Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt
Dec 22Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 24Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt
Jun 07When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?
May 10Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?
Mar 18We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings
Feb 16Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long
Jan 21
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 29Hissedar Getirileri
| MITRA | BE Pharmaceuticals | BE Pazar | |
|---|---|---|---|
| 7D | 0% | -1.5% | 1.9% |
| 1Y | -90.1% | 12.3% | 14.1% |
Getiri vs. Endüstri: MITRA underperformed the Belgian Pharmaceuticals industry which returned 12.5% over the past year.
Getiri vs Piyasa: MITRA underperformed the Belgian Market which returned 5.9% over the past year.
Fiyat Oynaklığı
| MITRA volatility | |
|---|---|
| MITRA Average Weekly Movement | 0% |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in BE Market | 7.2% |
| 10% least volatile stocks in BE Market | 2.2% |
İstikrarlı Hisse Senedi Fiyatı: MITRA has not had significant price volatility in the past 3 months.
Zaman İçindeki Volatilite: Insufficient data to determine MITRA's volatility change over the past year.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 1999 | 270 | Christophe Marechal | www.mithra.com |
Mithra Pharmaceuticals SA Temel Bilgiler Özeti
| MITRA temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | €12.14m |
| Kazançlar(TTM) | -€173.50m |
| Gelir(TTM) | €40.16m |
0.4x
P/S Oranı-0.1x
F/K OranıMITRA aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| MITRA gelir tablosu (TTM) | |
|---|---|
| Gelir | €40.16m |
| Gelir Maliyeti | €21.95m |
| Brüt Kâr | €18.21m |
| Diğer Giderler | €191.71m |
| Kazançlar | -€173.50m |
Son Raporlanan Kazançlar
Dec 31, 2023
Sonraki Kazanç Tarihi
Sep 26, 2024
| Hisse başına kazanç (EPS) | -2.51 |
| Brüt Marj | 45.34% |
| Net Kâr Marjı | -432.08% |
| Borç/Özkaynak Oranı | -258.9% |
MITRA uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görün